PHILADELPHIA -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000, and many patients are in the hospital again and again. But a tiny device is ...

PHILADELPHIA (WPVI) -- Heart failure is one of the most common reasons why seniors end up in the hospital. But a tiny, new device is helping to prevent that. Congestive heart failure can be very ...

Please provide your email address to receive an email when new articles are posted on . In late May, the FDA approved the CardioMEMS HF System for the measurement of pulmonary artery pressure and ...

A draft report from the Institute for Clinical and Economic Review (ICER) analyzes CardioMEMS and finds that the device's price would impose "excessive cost burdens" on the health care system. Marie ...

ST. PAUL, Minn. -- St. Jude Medical, Inc., a global medical device company, today announced a new data analysis from the CHAMPION clinical trial that evaluated outcomes in a subgroup of patients with ...

In a bid to fortify its Heart Failure business, Abbott ABT recently announced the start of the — GUIDE-HF clinical trial — largest heart failure medical device study in the United States. The trial ...

The FDA's Circulatory System Devices Panel sent a mixed message to the FDA today about CardioMEMS Champion HF Pressure Measurement System. The small implantable device provides provides daily ...

Global medical device company, St. Jude Medical Inc. (STJ) completed its acquisition of privately-held CardioMEMS, Inc. – the developer of the CardioMEMS Heart Failure (HF) System. The buyout followed ...

Boston Millennia Partners is pleased to announce that its portfolio company, CardioMEMS, Inc., an Atlanta based medical device company, has accepted a $60 million investment from and granted a $375 ...

PHILADELPHIA (WPVI) -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000 and many patients are in the hospital again and again. But a tiny device is ...

CardioMEMS, which is developing wireless medical devices to be used in treatment of heart ailments, is preparing to launch clinical trials and commercialization of its products with $14 million in the ...

Medical therapy for heart failure (HF) guided by an implanted pulmonary artery pressure (PAP) sensor didn't improve survival or risk for HF events like hospitalization over a year in a major ...